San Diego, CA, United States of America

Harun Rashid

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ambrx, Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harun Rashid: Innovator in Anti-CD3-Folate Conjugates

Introduction

Harun Rashid is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. His work focuses on innovative solutions that address critical health challenges.

Latest Patents

Harun Rashid holds a patent for "Anti-CD3-folate conjugates and their uses." This patent describes novel anti-CD3 antibodies conjugated to folate, which are designed for the treatment of diseases or conditions that would benefit from such conjugates. His innovative approach has the potential to enhance therapeutic efficacy in various medical applications.

Career Highlights

Harun Rashid is currently employed at Ambrx, Inc., a company known for its cutting-edge research in biopharmaceuticals. His role at Ambrx allows him to further explore and develop his ideas in a collaborative environment. With a focus on advancing medical treatments, he continues to push the boundaries of scientific research.

Collaborations

Throughout his career, Harun has worked alongside talented colleagues, including Feng Tian and Marco Gymnopoulos. These collaborations have fostered a dynamic exchange of ideas and have contributed to the success of their projects.

Conclusion

Harun Rashid is a dedicated inventor whose work in anti-CD3-folate conjugates exemplifies innovation in biotechnology. His contributions are paving the way for new therapeutic options that could significantly impact patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…